Rockville biopharma to sell first product on market in 28 years — but not in the U.S.

Rockville-based CASI Pharmaceuticals Inc. has earned approval in China to market a cancer therapy — its first commercial product in its nearly three decades of existence. The biopharmaceutical company has received clearance from the China National Medical Products Administration, China’s regulatory agency for drugs and medical devices, to launch an injection treatment for patients with mult iple myeloma, a blood cancer that forms in infection-fighting plasma cells. It’s a major milestone for…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news